Adverse Event Intake and Follow-up Services
ProPharma's contact center is trained on Adverse Event (AE) detection and intake since onboarding as part of Medical Information (MI) processing. We ensure that every AE is collected for patients' safety, customer journey, and compliance at every customer interaction. For a seamless experience, ProPharma offers comprehensive AE processing and reporting through our dedicated Pharmacovigilance (PV) team to supplement or fully outsource your existing PV function.
Central Point of Contact
As a trusted partner, ProPharma serves as an extension of your company, acting as a central hub for both your internal staff and external customers in the pre-marketing and post-marketing space. We speak the local language, and able to collect Adverse Events (AEs) and Special Safety Events (SSE) through various reporting channels, including traditional methods like phone and email, as well as newer platforms such as social media and live chat. The ProPharma Medical Information Contact Center (MICC) provides a centralized and streamlined AE reporting process, eliminating duplicate information from different programs and significantly reducing administrative complexity and time in AE processing.
Our global presence ensures easy approach to our contact center, even in crisis situations. Our scalable and adaptable strategies provide continuous business support during spikes in call volume, regulatory changes, or product market withdrawals, offering consistent medical information and safety assistance.
Empathy-Driven Approach
ProPharma's customer engagement strategy emphasizes empathy, transforming the treatment-emergent adverse events (TEAE) to a patient-centric intake experience. Our Medical Information (MI) specialists are trained to address unique patient concerns with compassion, fostering trust and enhancing satisfaction. By prioritizing open communication, we create a holistic support environment that leads to better patient outcomes and promotes a healthy relationship between our client and its stakeholders.
Identification and Accurate Reporting of Adverse Event
Our customizable AE intake process enhances quality with precision tailored to our client's specific needs. Our accredited MI Team not only experienced in identifying AEs but also in delivering comprehensive and accurate reporting. To ensure they remain at the forefront of a constantly evolving market, our specialists receive continuous training on the latest product knowledge and regulatory requirements. ProPharma's commitment to ongoing education promotes consistency and simplifies quality monitoring, resulting in a seamless and efficient process.
Documentation and Reporting
ProPharma provides an in-house validated database that integrates with Pharmacovigilance (PV) systems, such as Oracle Argus or Veeva Vault Safety, it is designed to simplify workflows, facilitating direct transfers of AE cases for immediate triage and review. With our advanced system, AE cases are delivered quickly to our clients or the ProPharma's dedicated PV teams, allowing for prompt assessment and action. Additionally, it triggers timely report to the regulatory system (i.e., FDA Adverse Event Reporting System (FAERS)), ensures that regulatory requirements are met. ProPharma empowers organizations to maintain high standards of compliance and safety while optimizing operational efficiency.
Follow-up Processing
Utilizing a contact center for Adverse Event Follow-Up (AEFU) provides several significant advantages. Our representatives are trained in pharmacovigilance protocols, ensuring accurate and relevant information is gathered during follow-up calls or communications. ProPharma offers proactive outreach service to patients and healthcare providers to obtain additional details that may not have been captured in the initial report, resulting in a more comprehensive understanding of adverse events. This approach improves operational efficiency, allowing your pharmacovigilance team to concentrate on critical tasks such as data analysis and regulatory compliance. Furthermore, standardized follow-up processes enhance consistency in data collection, which boosts the reliability of reports and aids in safety evaluations. Regular follow-ups also help build trust and engagement with patients and providers, reinforcing a commitment to safety and care.
Enhanced Reconciliation and Safety Monitoring
ProPharma's activity reporting process provide complete traceability of each AE case and delivers detailed insights into all AE activities. We promote transparency and accountability using systematic documentation. Our automated reconciliation process aligns AE cases between the MI and PV systems, cross-referencing AE case numbers in both databases. With access to our proprietary Business Insights & Analytics (BIA) reporting platform, you'll find comprehensive AE case data and program metrics available 24/7/365. This robust system enhances decision-making and reinforces our commitment to maintaining the highest standards of patient safety and operational efficiency.
ProPharma’s Advanced Contact Center Technology in Pharmacovigilance
Efficient Triage with IVR and Call Redirection
Our Interactive Voice Response (IVR) system and call redirection capabilities significantly enhance our triage processes. By efficiently routing calls to the appropriate representatives, we ensure that inquiries related to Adverse Events (AEs) are addressed promptly and accurately. This technology minimizes wait times and improves the overall experience for both patients and healthcare providers.
Smart Report Generation
Our smart report generation tool automates the merging of content directly from the intake process, greatly reducing the potential for errors associated with manual reporting. This streamlined case processing workflow not only improves accuracy but also expedites the generation of essential reports. As a result, our teams can dedicate more time to critical safety assessments and less to administrative tasks.
Automated Follow-Up
Our follow-up automation system streamlines the process of sending forms and collecting additional information through written communication, significantly reducing administrative workloads. By automating these follow-up tasks, we ensure timely communication with stakeholders while freeing up valuable resources within your team. This efficiency enhances our ability to maintain thorough and accurate records of all interactions related to AEs.
Advanced Analytics for Duplicated Reports
With advanced analytical tools, we can effectively reconcile the duplicated reports and information. This capability helps identify discrepancies and confirms that all data is accurately reflected in the systems. We help enhancing the integrity of data, which is crucial for making informed safety decisions and maintaining compliance with regulatory standards.
Our Adverse Event Intake Experts
-
Dave Bezick
Director, Medical Information
View Bio
-
Hannah Hunter
Director, Medical Information
View Bio
-
Katie Tonge
Director, Medical Information
View Bio
-
Leanne Shaw
Senior Director, Medical Information
View Bio
Dave Bezick
Hannah Hunter
Katie Tonge
Leanne Shaw
Subscribe for Updates
News & Insights
January 20, 2025
A Journey Through ProPharma's REMS Program Support
Explore how ProPharma's REMS program support services enhance patient safety, medication access, and regulatory compliance through fictional scenarios.
January 8, 2025
Patient Support Programs in India: Overcoming Barriers with Healthcare Access
Explore India's healthcare challenges, including affordability, rural access issues, and the role of Patient Support Programs in improving medication access.
January 6, 2025
Optimizing Clinical Trials: Balancing Patient Experience and Commercial Outcomes with Concierge Services
Explore how concierge services in clinical trials can enhance patient experience while balancing commercial outcomes. Discover insights and strategies for optimizing clinical trials.
October 21, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer
ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.
October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
September 24, 2024
ProPharma Honored in the 2024 Clinical Trials Excellence Awards
ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.
June 10, 2022
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
August 31, 2022
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...
News & Insights
January 6, 2025
Optimizing Clinical Trials: Balancing Patient Experience and Commercial Outcomes with Concierge Services
Explore how concierge services in clinical trials can enhance patient experience while balancing commercial outcomes. Discover insights and strategies for optimizing clinical trials.